Cardlytics Continues Revenue Tightening Among Worsening Economics (NASDAQ: CDLX)

.Financial writer encourages selling Cardlytics, Inc. due to dropping device business economics, income difficulties, and unfavorable financial trends. Click for this CDLX upgrade.